Women and Heart Disease

Heart disease in women was discussed as distinct from men’s heart disease. It was highlighted that heart disease ranks as the leading cause of death for both genders, with an increasing prevalence among women over the past decade, exacerbated by the effects of COVID-19. The discussion pointed out that traditional treatment guidelines primarily stem from studies conducted on men in the 1990s, underscoring a need for revised protocols that account for gender-specific differences in symptoms and risk factors. Women often exhibit atypical symptoms such as shortness of breath, nausea, and fatigue rather than the classic chest pain typical in men.

Preventive measures were emphasized, noting that lifestyle changes—including nutritious diet choices and regular physical activity—can prevent up to 90% of heart disease cases. Specific risk factors for women, such as autoimmune diseases, high blood pressure, high cholesterol, diabetes, and early menopause, were outlined. The importance of seeking medical attention promptly for any concerning symptoms, regardless of their atypical nature, was stressed to ensure early detection and effective management of heart health.